Factors governing the healing of Staphylococcus aureus infections following hip and knee prosthesis implantation: A retrospective study of 95 patients  by Joulie, D. et al.
Orthopaedics & Traumatology: Surgery & Research (2011) 97,  685—692
ORIGINAL ARTICLE
Factors  governing  the  healing  of  Staphylococcus
aureus  infections  following  hip  and  knee  prosthesis
implantation:  A  retrospective  study  of  95  patients
D.  Jouliea,1,∗, J.  Girarda,b,1, O.  Maresa,1,  E.  Beltrandc,1,
L.  Legoutd,1,  H.  Dezèquea,1,  H.  Migauda,b,1,  E.  Sennevilled,1
a C  Department  of  orthopaedics,  Roger  Salengro  Hospital,  Lille  Regional  Teaching  Hospital  Center,
boulevard  Prof-Emile-Laine,  59037  Lille,  France
b North  of  France,  Lille  University,  59000  Lille,  France
c Department  of  orthopaedic  surgery  and  traumatology,  Tourcoing  Hospital  Center,  155,  rue  du  Président-Coty,
BP 619,  59208  Tourcoing,  France
d Department  of  tropical  and  infectious  diseases,  Tourcoing  Hospital  Center,  155,  rue  du  Président-Coty,
BP 619,  59208  Tourcoing,  France
Accepted:  27  May  2011
KEYWORDS
Sepsis;
Hip  prosthesis;
Knee  prosthesis;
Antibiotics;
One-stage  revision;
Two-stage  revision;
Debridement;
Total  joint  infection
Summary
Introduction:  The  prognostic  factors  for  total  hip  arthroplasty  (THA)  and  total  knee  arthroplasty
(TKA) Staphylococcus  aureus  prosthetic  joint  infections  are  poorly  known,  notably  because  of
the heterogeneous  management  in  terms  of  both  antibiotic  administration  and  adopted  surgical
strategy.  Uniform  treatment  regimens  would  make  it  easier  to  deﬁne  the  outcome  of  these
S. aureus  infections.
Patients  and  methods:  Between  2001  and  2006,  95  patients  with  a  S.  aureus  joint  infection  after
THA or  TKA  were  treated,  strictly  following  a  standardized  protocol  according  to  the  recommen-
dations of  Zimmerli  et  al.  The  patients’  mean  age  was  65.7  years,  71  with  THA  and  28  with  TKA
(four patients  had  two  infected  joints).  These  95  patients  presented  120  infectious  episodes,  all
of whom  had  surgical  treatment:  53  lavages  (44.1%),  17  one-stage  prosthesis  revisions  (14.2%),
29 two-stage  prosthesis  revisions  (24.2%),  and  21  prostheses  removed  (17.5%).  On  the  intraop-
erative samples  taken,  methicillin-sensitive  S.  aureus  (MSSA)  was  isolated  in  88  patients  (73.3%)
and methicillin-resistant  S.  aureus  (MRSA)  in  18  patients  (15%);  ﬁnally  14  patients  were  included
because of  the  positive  results  of  preoperative  samples  taken.  Twenty-seven  infections  (22.5%)
were multibacterial,  including  at  least  S.  aureus  and  93  were  single  S.  aureus  bacteria.  Success
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was  deﬁned  at  a  minimum  12  months  of  follow-up  by  the  association  of  the  following  param-
eters: normal  erythrocyte  sedimentation  rate  (ESR)  and/or  C-reactive  protein  (CRP)  results,
noninﬂammatory  scar  with  no  ﬁstula,  no  surgical  revision,  and  no  antibiotic  treatment.
Results:  At  a  mean  follow-up  of  38  ±  24.9  months,  81  of  the  120  infectious  episodes  were
resolved (67.5%)  and  77  of  the  95  patients  were  healed  (81%).  Six  parameters  signiﬁcantly  inﬂu-
enced the  healing  of  the  infection:  initial  cementless  ﬁxation,  THA,  preoperative  knowledge
of the  bacterium,  immediate  postoperative  antibiotic  therapy  adapted  to  the  microbiological
data, changing  the  prosthesis,  and  monobacterial  infection.  Only  the  latter  two  were  indepen-
dent, with  an  odds  ratio  of  5  (1.6—14.9)  and  2.9  (1.1—7.7)  respectively.  However,  resistance  to
methicillin  did  not  appear  to  be  a  factor  of  failure.
Discussion:  Management  of  prosthetic  S.  aureus  infections  according  to  a  uniform  protocol  in  a
specialized  medical  center  healed  the  infection  in  81%  of  the  patients.  Treatment  improvement
requires knowledge  of  the  bacterium,  adaptation  of  immediate  probabilistic  antibiotic  therapy,
and preference  for  changing  the  prosthesis  over  simple  lavage.
Level of  evidence:  Level  IV,  retrospective  study,  no  control  group.
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he  mean  rate  of  infection  for  arthroplasties  is  1.25%  for
otal  hip  and  knee  arthroplasties,  varying  from  0.55%  to  2.4%
or  total  hip  arthroplasties  (THAs)  and  from  0.6%  to  1.77%  for
otal  knee  arthroplasties  (TKAs)  [1,2]. Gram-positive  bacte-
ia  are  the  most  frequent,  notably  Staphylococcus  aureus,
hich  accounts  for  22  to  35%  of  the  cases  reported  in  the
iterature  [1,2,3],  with  methicillin  resistance  encountered
n  0.54  to  9%  of  THA  and  TKA  joint  infections  [4,5]. The  efﬁ-
acy  of  the  therapeutic  protocols  is  judged  by  the  absence
f  recurrence  during  the  longest  monitoring  period  possi-
le,  with  a  minimum  of  1  to  2  years  recommended  [2,4,6].
 large  number  of  factors  inﬂuence  the  results,  including  the
atient  himself  and  his  co-morbidities,  the  type  of  implant,
he  type  of  infection,  and  the  treatment,  as  well  as  the  time
o  treatment  [6].
The  objective  of  this  study  was  to  determine  the  suc-
ess  rate  of  THA  and  TKA  S.  aureus  joint  infection  treatment
nd  to  specify  any  prognostic  factors.  This  study  was  con-
ucted  in  a  reference  center  for  the  treatment  of  complex
steoarticular  infections  (CRIOAC)  where,  since  1996,  the
ecommendations  made  by  Zimmerli  et  al.  [7]  have  been
pplied.
atients and methods
nclusion  criteria
he  patients  were  included  in  two  branches  of  the  north-
est  Lille-Tourcoing  CRIOAC  between  1  June  2001  and  30
une  2006.  A  single  team  of  infectious  disease  specialists
rospectively  applied  a  therapeutic  protocol  following  the
ecommendations  provided  by  Zimmerli  et  al.  [7],  adapt-
ng  them  to  the  framework  of  a  weekly  multidisciplinary
onsultation  meeting.
We  included  all  patients  who  had  a  hip  prosthesis  (total
r  hemiarthroplasty)  or  knee  prosthesis  (total  or  hinge)
ith  the  joint  infected  with  S.  aureus.  The  diagnosis  of
.  aureus  infection  was  made  based  on  at  least  one  reliable
ample  (preoperative  puncture,  bone  biopsy,  or  intraoper-
tive  sample)  that  resulted  in  a  positive  S.  aureus  culture.
t
1
F
psson  SAS.
.  aureus  infections  predating  the  arthroplasty  procedure,
ndocumented  infections,  and  patients  presenting  a  con-
raindication  to  medical-surgical  treatment  were  excluded,
ollowing  the  protocol.
Based  on  these  criteria,  106  patients  were  treated,  four
f  whom  presented  a  S.  aureus  infection  in  two  joints.
leven  patients  were  excluded  for  the  following  reasons:
ne  patient  was  in  litigation  with  the  hospital,  six  patients
ad  medical  ﬁles  that  could  not  be  used,  and  four  patients
ere  lost  to  follow-up.
Each  surgical  intervention  (drainage  or  lavage,  one-
r  two-stage  prosthesis  revisions,  prosthesis  removal)  was
ounted  as  a  single  clinical  episode.  This  study  analyzed  99
ip  (n  =  71)  and  knee  (n  =  28)  arthroplasties  with  S.  aureus
nfection  in  95  patients  who  presented  120  different  clinical
pisodes  (21  patients  underwent  several  infectious  clinical
pisodes  following  the  arthroplasties  included  in  the  study).
atients
he  mean  age  at  the  time  of  the  ﬁrst  infection  was  65.7  ±  6
ears  (range,  16—96  years);  (42  males,  53  females).  Eighty-
ine  patients  (93%)  had  at  least  one  co-morbidity  and  60
63%)  at  least  two  (Table  1).  For  83  patients,  this  was  an
rthroplasty  of  an  untreated  joint,  whereas  16  patients
ad  already  undergone  one  or  several  interventions  before
mplantation  of  the  prosthesis  studied.  The  indications
or  arthroplasty  were  the  following:  59  cases  of  primary
steoarthritis,  six  cases  of  post-traumatic  arthrosis,  eight
ases  of  osteoarthritis  with  dysplasia,  12  fractures,  four
umors,  three  cases  of  osteonecrosis  of  the  femoral  head,
nd  seven  cases  of  rheumatoid  arthritis.  There  were  62  THAs
62.6%),  22  TKAs  (22.2%),  six  knee  hinge  prostheses  (6.1%),
nd  nine  hemi-arthroplasty  of  hip  (9.1%).  Implant  ﬁxation  is
etailed  in  Table  2.
The  infections  were  classiﬁed  as  reported  in  Tsukayama
t  al.  [8].  Of  the  120  infections,  there  were  21  early  infec-
ions  (17.5%)  (up  to  1  month  after  surgery),  31  late  infections
25.8%)  (from  the  30th  postoperative  day  to  the  end  of
he  1st  year),  45  chronic  infections  (37.5%)  (beyond  the
st  year),  and  23  acute  hematogenous  infections  (19.2%).
orty-six  of  the  120  infectious  episodes  (61.6%)  were  accom-
anied  by  a  ﬁstula.  Preoperative  knowledge  of  the  infecting
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Table  1  Analysis  of  the  inﬂuence  of  co-morbidity  factors  on  infection  healing.
Healed  patients  Unhealed  patients  P
Mean  age  at  time  of  infection  66  years  (18—96)  65  years  (18—94)  NS
Diabetes (n  =  30)  63%  37%  NS
Vascular disorder  in  lower  limbs  (n  =  36)  63%  37%  NS
Rheumatoid arthritis  (n  =  7)  70%  30%  NS
Immunosuppression  (n  =  16)  87.5%  12.5%  NS
Evolutive neoplasia  (n  =  7) 86% 14% NS
Alcohol  intoxication  (n  =  37) 76% 24% NS
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pathogen  was  based  on  joint  puncture  performed  with  radio-
scopic  monitoring  for  69  patients  (57.5%)  and  surgical  biopsy
for  seven  patients  (5.8%).  These  different  exams  demon-
strated  a  bacterium  before  revision  in  35.5%  of  the  cases
in  the  overall  series  (27  out  of  the  76  acts  performed  preop-
eratively).
Intervention,  bacteriological  data,  and  antibiotic
treatment
The  mean  time  between  the  onset  of  infectious  signs  and
the  medical-surgical  management  was  141.5  days  ±  236.4
days  (range,  1—1460  days).  Four  types  of  intervention  were
performed  for  the  120  infectious  episodes:  53  lavages  with-
out  changing  the  implant,  17  one-stage  implant  revisions,
29  two-stage  implant  revisions,  and  21  prosthesis  removals
(followed  by  arthrodesis  or  head/neck  resection).  A  syn-
ovectomy  that  was  as  complete  as  possible  was  associated
in  all  cases.  The  choice  between  the  different  procedures
followed  the  recommendations  of  Zimmerli  et  al.  [7]  by
adapting  the  use  of  antibiotics  to  their  sensitivity  and  to
any  contraindications  to  antibiotic  use;  prosthesis  removal
was  reserved  for  patients  who  had  undergone  multiple  pro-
cedures  with  repeated  failure.
Pre-  and  intraoperative  samples  systematically  associ-
ated  a  standard  bacteriological  sample  and  direct  seeding
on  liquid  enriched  with  Rosenow  medium  [9],  with  a
mean  6.6  ±  3.6  samples  (range,  1—16)  taken  per  interven-
tion.  A  strain  of  S.  aureus  was  isolated  for  each  patient,
from  either  preoperative  samples  (n  =  14)  or  intraopera-
tive  samples  (n  =  106).  The  proportion  of  S.  aureus  strains
resistant  to  methicillin  (MRSA)  was  23%  for  preopera-
tive  samples  (3/14)  and  15%  for  intraoperative  samples
(16/106).  Twenty-seven  infectious  episodes  (22.5%)  were
s
p
d
a
Table  2  Healing  rate  for  infection  depending  on  type  of  original  
for two  patients).
Type  of  prosthesis  ﬁxation  Number  of  patients
Cement  53  (45%)  
Cementless 24  (20%)  
Hybrid 41  (35%)  
P 21% NS
ultibacterial,  associating  another  bacterium  (Enterococ-
us  spp.,  coagulase-negative  Staphylococcus,  Serratia  spp.,
scherichia  coli) with  S.  aureus.
The  postoperative  probabilistic  antibiotic  therapy  (third-
r  fourth-generation  vancomycin  +  cephalosporin)  was
dapted  if  it  responded  to  the  intraoperative  microbiolog-
cal  results  and  if  it  was  started  as  soon  as  intraoperative
amples  were  ﬁnished  and  continued  until  replaced  by  per
s  adapted  antibiotic  therapy  (this  was  the  case  for  111
f  120  infectious  episodes  [92.5%]).  The  mean  duration  of
ntravenous  probabilistic  antibiotic  therapy  was  7  ±  6  days
range,  1—35  days).  All  antibiotic  treatments  administered
eyond  this  probabilistic  treatment  were  adapted  to  the
ensitivity  of  the  bacteria  found  during  intraoperative
nd/or  preoperative  sampling.  Dual  antibiotic  therapy
ncluding  rifampicin  was  prescribed  for  62  patients  (63.9%),
ith  this  antibiotic  always  used  in  association,  and  was
ystematically  chosen  when  there  was  no  contraindication.
he  mean  duration  of  deﬁnitive  antibiotic  therapy  was
22.3  ±  64.6  days  (range,  3—372  days)  (the  patient  with
nly  3  days  of  antibiotic  treatment  demonstrated  multiple
ntolerances  to  the  antibiotics,  experienced  infectious
ailure,  and  died  at  1  month).
valuation  of  the  results
or  the  surviving  patients,  the  results  were  assessed  at  a
ean  follow-up  of  38  ±  24.9  months  (range,  12—90  months).
he  medical  ﬁles  were  evaluated  and  all  the  patients  were
ontacted  by  telephone  to  determine  the  status  of  their
car,  the  results  of  their  last  biological  workup  (ESR,  CRP)  (a
rescription  was  sent  to  them  if  their  last  workup  had  been
one  more  than  3  months  before),  any  antibiotic  taken,  and
ny  surgical  revision  performed.  At  the  last  follow-up,  at  a
arthroplasty  ﬁxation  (n  =  118  with  missing  initial  ﬁxation  data
All  joints  combined
Healed  Unhealed
30  (57%)  23  (43%)
21  (88%)  3  (12%)
29  (71%)  12  (29%)
<  0.05  <  0.05
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Table  3  Infection  healing  rate  depending  on  time  to  management  (between  contamination  and  intervention)  in  days  and  by
type of  intervention.
Healed  Unhealed  P
All  surgical  procedures  combined  157  ±  266  (0—1460)  108  ±  108  (0—602)  NS
Lavages 120  ±  324.04  (0—1460)  86  ±  174.43  (0—602)  NS
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DAll surgical procedures combined: lavage, one-stage prosthesis re
inimum  of  12  months,  a  patient  was  considered  healed  if
e  or  she  presented  all  the  following  signs:
1) ESR  and/or  CRP  normal;
2) and  a  noninﬂammatory  scar  with  no  ﬁstula;
3)  and  had  never  taken  antibiotics  for  the  arthroplasty
since  discharge;
4) and  had  never  been  reoperated  for  the  arthroplasty.
Pain  was  not  judged  to  be  a  valid  criteria  because  of
he  number  of  operations  undergone  by  the  patients.  This
as  also  true  for  the  radiological  criteria,  which  are  not
redictive  of  infection  healing.
Twenty-two  patients  (23%)  had  died  at  a  mean  follow-up
f  12  months  (range,  1—30  months).  The  patients  who  had
ied  before  1  year  were  considered  unhealed  and  for  the
atients  who  died  after  1  year,  the  four  healing  criteria  had
een  observed  such  that  among  these  22  deaths,  six  were
onsidered  healed  and  16  unhealed.
tatistical  analysis
he  statistical  analysis  was  done  with  Stat  ViewTM and  SASTM
oftware.  Univariate  analyses  were  performed  using  the  Chi2
est  for  categorical  variables,  with  Yates  correction  for  the
mall  numbers  of  patients.  Analyses  of  variance  were  used
or  comparisons  of  means  and  regression  tests  for  quantita-
ive  variables.  The  univariate  analyses  identiﬁed  the  factors
aving  an  inﬂuence  on  the  healing  of  infection.  The  inde-
endence  of  these  factors  was  evaluated  using  logistical
egression  and  their  level  of  inﬂuence  was  determined  by
alculating  the  odds  ratios  (with  95%  conﬁdence  interval).
he  signiﬁcance  level  was  established  at  5%.
esults
fter  38  ±  24.9  months  (range,  12—90  months)  of  follow-
p,  81  of  the  120  infectious  episodes  had  healed  (67.5%)
nd  77  of  the  95  patients  were  considered  healed  (81%).
either  age  at  arthroplasty  nor  any  of  the  co-morbidity  fac-
ors  had  a  signiﬁcant  inﬂuence  on  the  healing  rate,  whether
hey  were  isolated  or  associated  (Table  1).  Similarly,  neither
he  number  of  interventions  before  prosthesis  implanta-
ion  (0.22  ±  0.57  in  healed  patients  versus  0.23  ±  0.62  in
nhealed  patients  [NS])  nor  the  indication  for  arthroplasty
igniﬁcantly  inﬂuenced  the  healing  rate  (NS).
On  the  other  hand,  the  healing  rate  was  higher  for  the
HA  patients  (47/62  [75%])  compared  to  the  TKA  patients
14/22  [63.6%]),  the  hemi-arthroplasty  of  hip  (4/9  [44%]),
nd  hinge  knee  implants  (2/6  [33%];  P  <  0.05).  Overall,  the
ealing  rate  was  72%  (51/71)  for  the  hip  arthroplasties  (THA
T
r
a
p, two-stage prosthesis revision, and prosthesis removal.
nd  hemi-arthroplasty  of  hip)  and  57%  (16/28)  for  the  knee
rthroplasties  (TKA  and  hinge  prostheses)  (NS).  The  heal-
ng  rate  differed  depending  on  the  implant  ﬁxation  method,
ith  a  better  prognosis  for  the  cementless  arthroplasties
P  <  0.05)  (Table  2).
The  time  from  infectious  signs  to  surgical  management,
ncluding  cases  undergoing  simple  lavage,  had  no  inﬂuence
n  the  healing  rate  (Table  3).  For  the  simple  lavages,  the  37
ases  managed  with  this  treatment  before  1  month  after  the
nset  of  infectious  signs  had  a  57%  success  rate  against  the
nfection  (21/37)  versus  62%  (10/16)  of  the  lavages  carried
ut  beyond  1  month  (NS).
The  type  of  infection  or  the  presence  of  a ﬁstula  did
ot  signiﬁcantly  modify  the  healing  rate  in  the  120  cases
f  infection  (NS)  (Table  4).  On  the  other  hand,  preoper-
tive  identiﬁcation  of  the  pathogens  was  correlated  with
 higher  healing  rate  (P  <  0.05)  (Table  4).  Similarly,  pros-
hesis  revisions  (in  one-  or  two-stages)  showed  a  higher
ate  of  infection  healing  than  lavages  or  prosthesis  removal
P  =  0.0005)  (Table  4).  If  analysis  is  limited  to  the  hip  revi-
ions,  the  healing  rate  of  one-stage  revisions  was  94%
15/16)  versus  86%  (19/22)  for  the  two-stage  revisions  (NS).
The  healing  rate  was  not  inﬂuenced  by  methicillin  resis-
ance  (NS)  (Table  5).  However,  monomicrobial  infections
howed  a  higher  healing  rate  than  polymicrobial  infections
P  <  0.05)  (Table  4).  Adaptation  of  the  probabilistic  antibi-
tic  therapy  inﬂuenced  the  infection-healing  rate  (P  <  0.05)
Table  4).  On  the  other  hand,  neither  the  duration  of  the
ntravenous  probabilistic  therapy  (7  ±  5.2  days  in  cases  of
ealing  versus  7.8  ±  7.4  days  when  the  infection  was  not
ealed)  nor  the  total  duration  of  the  antibiotic  therapy
124  ±  62  days  in  healed  cases  versus  117.9  ±  69  days  with
he  infection  not  healed)  had  a  signiﬁcant  inﬂuence  on  the
nfection  healing  rate  (NS).
Of  the  six  parameters  that  had  a  signiﬁcant  favorable
nﬂuence  on  the  S.  aureus  infection  healing  rate  (infection
f  a  cementless  arthroplasty,  THA  infection,  bacteriology
nown  before  surgery,  prescription  of  adapted  probabilistic
ostoperative  antibiotic  therapy,  one-  or  two-stage  pros-
hesis  revision,  and  monomicrobial  infection),  only  the
ast  two  were  independent  factors,  with  an  odds  ratio  of
 (1.6—14.9)  for  prosthesis  revisions  versus  lavages  and
rosthesis  removal  and  2.9  (1.1—7.7)  for  monomicrobial
nfections  versus  polymicrobial  infections.
iscussionhe  objective  of  this  study  was  to  determine  the  healing
ate  for  S.  aureus  joint  infection  following  THA  or  TKA  in
 reference  medical  center  with  application  of  a  speciﬁc
rotocol  by  a  multidisciplinary  team.  In  terms  of  healing
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Table  4  Healing  rate  depending  on  type  of  infection,  surgical  procedure,  presence  of  a  ﬁstula,  preoperative  identiﬁcation  of
bacterium, and  infection  being  monobacterial.
Healed  (%) Unhealed  P
Type  of  infection
Early  14  (67%)  7  NS
Late 18  (58%)  13
Chronic 32  (71%)  13
Acute hematogenic 17 (74%)  6
Presence of  ﬁstula
Without  ﬁstula 50 (67%)  24 NS
With ﬁstula 31 (67%)  15
Preoperative  identiﬁcation  of  bacterium
Bacterium  identiﬁed  preoperatively  48  (75%)  16  <  0.05
Bacterium not  identiﬁed  preoperatively  33  (59%)  23
Type of  intervention
One-stage  prosthesis  revision 15 (94%)  2 0.0005
Two-stage prosthesis  revision 25 (86.2%)  4
Lavages 30 (57%)  23
Prosthesis removal 10 (34%)  11
Mono- or  polymicrobial  infection
Monomicrobial  68  (73%)  25  <  0.05
Polymicrobial  13  (48%)  14
Probabilistic  antibiotic  therapy  adaptation
Adapted  78  (70%)  33  <  0.05
3  (3
(Not adapted  
with  a  surgical  intervention,  the  rate  was  only  67.5%,  which
may  seem  low,  but  the  healing  rate  per  patient  was  81%,
which  is  near  the  results  published  in  the  literature  [10]. We
concentrated  on  S.  aureus  joint  infections  because  of  their
frequency  and  most  particularly  to  make  the  study  more
homogeneous.  This  procedure  is  rare,  with  only  two  studies
evaluating  only  S.  aureus  infections  on  implants  identiﬁed  in
the  literature,  which  found  comparable  results  [4,10].
The  secondary  objective  was  to  determine  the  factors
inﬂuencing  the  healing  of  a  hip  or  knee  S.  aureus  joint  infec-
tion.  Six  factors  inﬂuenced  the  healing  rate:(1) for  three  factors,  the  medical-surgical  team  cannot
inﬂuence  the  course  of  the  disease:  the  type  of
arthroplasty  (better  rate  for  THAs),  cementless  ﬁxation
Table  5  Healing  rate  depending  on  the  surgical  technique  Staphy
MSSAa
All  procedures  combined 67.6%  (67/99)  
Lavage 57.5%  (24/42)  
One-stage prosthesis  revision  93%  (14/15)  
Two-stage prosthesis  revision  88.4%  (22/26)  
Prosthesis removal  43.7%  (7/16)  
MSSA: methicillin-sensitive S. aureus;  MRSA: methicillin-resistant S. aur
a A total of 88 intraoperative S. aureus cultures were sensitive to m
which 11 MSSA and three MRSA identiﬁed on the preoperative cultures3%)  6
(better  rate  for  cementless  ﬁxation),  and  polymicrobial
infections  with  a  higher  failure  rate;
2)  for  three  additional  factors,  the  managing  team
can  inﬂuence  the  healing  rate  by  attempting  to
determine  the  type  of  bacterium  preoperatively,
limiting  the  use  of  simple  lavage  in  favor  of
one-  or  two-stage  prosthesis  revision,  and  adapt-
ing  the  probabilistic  antibiotic  therapy.  The  inﬂuence
of  success  factors  is  variably  appreciated  in  the
literature:
(a) Brandt  et  al.  [11]  observed  no  difference  between
THA  and  TKA  S.  aureus  infections  treated  by  one-  or
two-stage  prosthesis  revision,
(b)  Vielpeau  and  Lortat  Jacob  [6]  observed  an  identical
success  rate  between  one-  and  two-stage  prosthesis
revisions  in  infected  joints.
lococcus.  aureus  sensitivity  to  methicillin.
MRSAa P
67%  (14/21)  NS
55.6%  (6/11)  NS
100%  (2/2)  NS
100%  (3/3)  NS
60%  (3/5)  NS
eus.
ethicillin (MSSA) and 18 were resistant to methicillin (MRSA), to
 must be added.
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The  present  study  is  the  ﬁrst  to  report  a  better  heal-
ng  rate  for  cementless  prostheses  compared  to  cemented
mplants.  This  result  was  suggested  by  Vielpeau  and  Lortat
acob  [6],  who  reported  a  higher  success  rate  for  revisions
f  a  single  infected  THA  implant  when  the  component  left
n  place  was  cementless.  This  result  can  be  explained  by  a
maller  number  of  interfaces  for  the  cementless  prosthesis.
Presence  of  a  ﬁstula  is  often  considered  detrimental  to
he  healing  of  a  joint  infection  [12,13].  Raut  et  al.  [12]
btained  86%  healing  in  57  single-stage  total  hip  prosthe-
is  revisions  infected  with  ﬁstula,  but  with  a  heterogeneous
acterial  population  (including  only  11  cases  of  S.  aureus).
or  the  infected  knee  joints,  Silva  et  al.  [13]  observed  a
ower  healing  rate  in  patients  presenting  an  active  ﬁstula
efore  surgery.  The  present  series  differs  in  that  it  demon-
trates  that  the  presence  of  a  ﬁstula  does  not  modify  the
ealing  rate;  however,  we  treated  a  single  type  of  bacterium
ith  a  uniform  protocol.
Knowledge  of  the  responsible  bacterium  before  surgical
evision  was  a  success  factor  in  this  study.  Hip  and  knee
uncture  has  been  reported  to  be  valuable  in  the  literature,
ith  sensitivity  varying  from  84%  to  100%  and  speciﬁcity
rom  57%  to  100%  [14—16], but  we  believe  that  it  should
ot  be  neglected  given  that  it  is  a  simple  exam  diagnosing
nfection  and  identifying  the  causal  bacterium  [14—16]. No
tudies  were  found  that  evaluated  the  impact  of  preopera-
ive  knowledge  of  the  causal  bacterium  on  the  healing  rate.
ts  favorable  inﬂuence  can  be  explained  by  the  fact  that  in
hese  situations,  probabilistic  postoperative  antibiotic  ther-
py  has  a  greater  chance  of  being  optimal  [17].
In  the  present  study,  a  period  of  less  than  4  to  6
eeks  between  implantation  or  the  beginning  of  infec-
ion  and  surgical  management  was  not  associated  with  a
etter  healing  rate  [6].  The  role  to  be  played  by  simple
avage  needs  to  be  better  deﬁned,  even  if  this  treatment
an  be  easily  administered  to  fragile  patients  (4.6,10).
e  observed  no  differences  in  the  infection  healing  rate
etween  one-  and  two-stage  implant  revision,  but  the
tudy’s  protocol  reserved  single-intervention  procedures
or  cases  demonstrating  all  the  favorable  factors  [18—20],
hereas  prosthesis  removal  was  reserved  for  patients  who
ad  undergone  several  surgeries  with  repeated  failure  in
erms  of  infection  healing  [6].
No  studies  were  found  in  the  literature  with  one-  or  two-
tage  prosthesis  revisions  in  cases  of  S.  aureus  infection.
randt  et  al.  [11]  reported  on  S.  aureus-infected  joints  after
otal  hip  and  knee  replacement,  but  treatment  included
early  exclusively  two-stage  implant  revisions,  resulting  in
 97.2%  healing  rate  at  5  years  for  these  two-stage  revi-
ions.  The  present  study  suggests  that  in  a  population  of
.  aureus-infected  THA  joints,  single-stage  prosthesis  revi-
ion  gives  the  same  results  as  a  two-stage  revision,  whatever
he  preoperative  clinical  condition  (whether  or  not  there
s  a  ﬁstula),  the  presentation  of  the  infection  (acute  or
hronic),  and  the  methicillin  sensitivity  (MSSA  or  MRSA)  may
e.
The  bacteria  most  often  encountered  in  hip  and  knee
rthroplasties  are  S.  aureus  and  coagulase-negative  staphy-
ococci  [2,8,21].  The  proportion  of  S.  aureus  infections
aries  from  18.6%  to  35%  [21—23]  and  the  proportion  of
RSA  compared  to  MSSA  varies  from  0%  for  Tsukayama  et  al.
8]  to  50%  for  Harwood  et  al.  [24]. In  the  present  series,
C
T
mD.  Joulie  et  al.
he  proportion  of  MRSA  in  intraoperative  cultures  is  15%  (18
ases),  with  no  inﬂuence  on  the  chances  of  healing  (Table  5),
hich  could  at  least  partially  explain,  given  the  systematic
se  of  rifampicin  (except  when  contraindicated),  that  this
ntibiotic  has  a  practically  equivalent  anti-staphylococcic
ctivity,  whether  or  not  the  strain  is  sensitive  or  resis-
ant  to  methicillin  [25]. When  carrying  out  only  surgical
avages,  Barberán  et  al.  [10]  observed  a lower  healing  rate
or  MRSAs,  and  in  multivariate  analysis  Salgado  et  al.  [4]
emonstrated  that  MRSA  infection  associated  with  the  hip
nd  lavage  treatment  or  one-stage  prosthesis  revision  com-
ined  with  antibiotic  therapy  not  including  rifampicin  was
 failure  factor  for  S.  aureus  infections  (odds  ratio,  9.2
2.4—35.4]).
The  majority  of  prosthesis  infections  are  monobacterial,
ith  a  rate  varying  from  75%  to  91%  [8,21,22].  Out  of  1299
nfected  hip  prostheses,  Jackson  et  al.  [26]  showed  that
olymicrobial  infections  are  a  factor  of  failure.  For  102
nfected  hip  joints  treated  with  prothesis  revision,  Sanzen
t  al.  [27]  observed  81.3%  (74/91)  healing  in  monobacte-
ial  infections  versus  27%  (3/11)  in  polymicrobial  infections.
he  present  series  conﬁrms  the  gravity  of  this  factor,  which
ppeared  to  be  independent  in  multivariate  analysis.  This
eature  has  a  negative  effect  in  making  probabilistic  post-
perative  antibiotic  therapy  and  its  later  adaptation  more
ifﬁcult,  notably  reducing  treatment  compliance  because  of
he  multiplication  of  antibiotics.
No  consensus  currently  exists  on  the  duration  (parenteral
nd  oral)  of  the  antibiotic  therapy  for  hip  and  knee  joint
.  aureus  infections  [28—30]. Various  teams  agree  on  a  few
oints:  dual  antibiotic  therapy,  intraoperative  IV  antibiotics
elayed  by  oral  antibiotics,  and  antibiotic  therapy  adapted
o  the  antibiogram  [28—31]. For  the  choice  of  antibiotics,
f  there  is  no  contraindication,  it  seems  that  the  asso-
iation  of  rifampicin  and  quinolones  ensures  the  highest
uccess  rate  [6,25,28—31]. The  literature  reports  indicate
hat  MRSAs  are  treated  with  glycopeptides  (vancomycin  or
eicoplanin),  but  no  studies  have  corroborated  this  choice
6].  Use  of  linezolid  is  limited  by  substantial  accumulated
oxicity,  notably  hematologic,  and  daptomycin  has  not  yet
een  used  on  a  large  scale  in  this  indication  despite  demon-
trated  efﬁcacy  on  staphylococci  in  the  exponential  growth
hase  and  stationary  in  conditions  of  bioﬁlm  associated  with
owerful  concentration-dependent-type  bactericidal  action
24,31,32].
This  study  underscores  the  need  for  early  well-adapted
ntibiotic  therapy  while  waiting  for  the  results  of  the
ntibiogram  on  intraoperative  cultures.  No  studies  that  had
valuated  the  role  played  by  probabilistic  antibiotic  treat-
ent  were  found  in  the  literature.  This  study  presents
imitations  related  to  the  retrospective  design  and  the
bsence  of  a  control  group.  However,  it  assessed  a  single
edical-surgical  protocol  set  up  prospectively  by  a  single
edical  team  and  underlines  the  decisive  role  of  the  infec-
ious  disease  specialist  within  this  team,  notably  for  the
ndividualized  adjustment  and  follow-up  of  treatments.onclusion
he  results  of  this  study  establish  that  by  following  a
anagement  protocol  inspired  by  the  work  published  by
ic  jo
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Zimmerli  et  al.  [7],  the  success  rate  for  medical-surgical
treatment  in  a  specialized  center  of  a  knee  or  hip  joint
S.  aureus  infection  following  implantation  is  81%.  Improve-
ment  of  these  patients’  prognosis  is  based  on  better
management  including  the  identiﬁcation  of  the  causal  bac-
teria,  limitation  of  lavages  with  preference  for  prosthesis
revision,  and  prescription  of  probabilistic  postoperative
antibiotic  therapy  adapted  to  the  results  of  intraoperative
prosthetic  joint  samples.
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